Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome

Gut Pathogens

Volumn 2, Issue 1, 2010, Pages

  Carroll, Ian M ^a   Chang, Young Hyo ^b   Park, Jiwon ^a   Sartor, R Balfour ^a   Ringel, Yehuda ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80051785670     PISSN: None     EISSN: 17574749     Source Type: Journal    
DOI: 10.1186/1757-4749-2-19     Document Type: Article

References (30)

1. Functional bowel disorders. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC, Gastroenterology 2006 130 5 1480 1491 10.1053/j.gastro.2005.11.061 16678561
2. The functional gastrointestinal disorders and the Rome III process. Drossman DA, Gastroenterology 2006 130 5 1377 1390 10.1053/j.gastro.2006.03.008 16678553
3. Alterations in the intestinal microbiota and functional bowel symptoms. Ringel Y, Carroll IM, Gastrointest Endosc Clin N Am 2009 19 1 141 150 vii 10.1016/j.giec.2008.12.004 19232285
4. Irritable bowel syndrome. Ringel Y, Sperber AD, Drossman DA, Annu Rev Med 2001 52 319 338 10.1146/annurev.med.52.1.319 11160782 (Pubitemid 32195328)
5. Mechanisms of hypersensitivity in IBS and functional disorders. Azpiroz F, Bouin M, Camilleri M, Mayer EA, Poitras P, Serra J, Spiller RC, Neurogastroenterol Motil 2007 19 1 Suppl 62 88 10.1111/j.1365-2982.2006.00875.x 17280586 (Pubitemid 46058983)
6. Mycobacterium avium subspecies paratuberculosis infection in cases of irritable bowel syndrome and comparison with Crohn's disease and Johne's disease: common neural and immune pathogenicities. Scanu AM, Bull TJ, Cannas S, Sanderson JD, Sechi LA, Dettori G, Zanetti S, Hermon-Taylor J, J Clin Microbiol 2007 45 12 3883 3890 10.1128/JCM.01371-07 17913930 (Pubitemid 350274866)
7. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. Rodriguez LA, Ruigomez A, Bmj 1999 318 7183 565 566 10037630 (Pubitemid 29188957)
8. Is IBS caused by infectious diarrhea? Nat Clin Pract Gastroenterol Hepatol. Spiller RC, 2007 4 12 642 643 17984983
9. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study. Pimentel M, Chow EJ, Lin HC, Am J Gastroenterol 2003 98 2 412 419 12591062 (Pubitemid 36232393)
10. Review of rifaximin as treatment for SIBO and IBS. Pimentel M, Expert Opin Investig Drugs 2009 18 3 349 358 10.1517/13543780902780175 19243285
11. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Pimentel M, Chow EJ, Lin HC, Am J Gastroenterol 2000 95 12 3503 3506 10.1111/j.1572-0241.2000.03368.x 11151884
12. The fecal microbial population in the irritable bowel syndrome. Balsari A, Ceccarelli A, Dubini F, Fesce E, Poli G, Microbiologica 1982 5 3 185 194 7121297 (Pubitemid 13228114)
13. Intestinal microecology and quality of life in irritable bowel syndrome patients. Si JM, Yu YC, Fan YJ, Chen SJ, World J Gastroenterol 2004 10 12 1802 1805 15188510
14. A Molecular Analysis of Fecal and Mucosal Bacterial Communities in Irritable Bowel Syndrome. Codling C, O'Mahony L, Shanahan F, Quigley EM, Marchesi JR, Dig Dis Sci 2010 55 2 392 397 10.1007/s10620-009-0934-x 19693670
15. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Kassinen A, Krogius-Kurikka L, Makivuokko H, Rinttila T, Paulin L, Corander J, Malinen E, Apajalahti J, Palva A, Gastroenterology 2007 133 1 24 33 10.1053/j.gastro.2007.04.005 17631127 (Pubitemid 47031125)
16. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Malinen E, Rinttila T, Kajander K, Matto J, Kassinen A, Krogius L, Saarela M, Korpela R, Palva A, Am J Gastroenterol 2005 100 2 373 382 10.1111/j.1572-0241.2005.40312.x 15667495 (Pubitemid 40314522)
17. Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome - a longitudinal study in IBS and control subjects. Matto J, Maunuksela L, Kajander K, Palva A, Korpela R, Kassinen A, Saarela M, FEMS Immunol Med Microbiol 2005 43 2 213 222 10.1016/j.femsim.2004.08.009 15747442 (Pubitemid 40170291)
18. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. Swidsinski A, Weber J, Loening-Baucke V, Hale LP, Lochs H, J Clin Microbiol 2005 43 7 3380 3389 10.1128/JCM.43.7.3380-3389. 2005 16000463 (Pubitemid 40981351)
19. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Tana C, Umesaki Y, Imaoka A, Handa T, Kanazawa M, Fukudo S, Neurogastroenterol Motil 2010 22 55 512 519 19903265
20. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. Krogius-Kurikka L, Lyra A, Malinen E, Aarnikunnas J, Tuimala J, Paulin L, Makivuokko H, Kajander K, Palva A, BMC Gastroenterol 2009 9 95 10.1186/1471-230X-9-95 20015409
21. Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification. Lyra A, Rinttila T, Nikkila J, Krogius-Kurikka L, Kajander K, Malinen E, Matto J, Makela L, Palva A, World J Gastroenterol 2009 15 47 5936 5945 10.3748/wjg.15.5936 20014457
22. Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Zoetendal EG, von Wright A, Vilpponen-Salmela T, Ben-Amor K, Akkermans AD, de Vos WM, Appl Environ Microbiol 2002 68 7 3401 3407 10.1128/AEM.68.7.3401-3407.2002 12089021 (Pubitemid 34734038)
23. Interdigestive myoelectric complex in germ-free rats. Caenepeel P, Janssens J, Vantrappen G, Eyssen H, Coremans G, Dig Dis Sci 1989 34 8 1180 1184 10.1007/BF01537265 2752868 (Pubitemid 19202111)
24. Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Husebye E, Hellstrom PM, Sundler F, Chen J, Midtvedt T, Am J Physiol Gastrointest Liver Physiol 2001 280 3 368 380 11171619
25. Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. Kerckhoffs AP, Samsom M, van der Rest ME, de Vogel J, Knol J, Ben-Amor K, Akkermans LM, World J Gastroenterol 2009 15 23 2887 2892 10.3748/wjg.15.2887 19533811
26. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Matsuki T, Watanabe K, Fujimoto J, Takada T, Tanaka R, Appl Environ Microbiol 2004 70 12 7220 7228 10.1128/AEM.70.12.7220-7228.2004 15574920 (Pubitemid 39643786)
27. Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. Rinttila T, Kassinen A, Malinen E, Krogius L, Palva A, J Appl Microbiol 2004 97 6 1166 1177 10.1111/j.1365-2672.2004.02409.x 15546407 (Pubitemid 39573940)
28. Comparison of real-time PCR with SYBR Green I or 5'-nuclease assays and dot-blot hybridization with rDNA-targeted oligonucleotide probes in quantification of selected faecal bacteria. Malinen E, Kassinen A, Rinttila T, Palva A, Microbiology 2003 149 Pt 1 269 277 10.1099/mic.0.25975-0 12576600 (Pubitemid 36175697)
29. Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Bartosch S, Fite A, Macfarlane GT, McMurdo ME, Appl Environ Microbiol 2004 70 6 3575 3581 10.1128/AEM.70.6. 3575-3581.2004 15184159 (Pubitemid 38745906)
30. Quantitative real-time PCR using TaqMan and SYBR Green for Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, tetQ gene and total bacteria. Maeda H, Fujimoto C, Haruki Y, Maeda T, Kokeguchi S, Petelin M, Arai H, Tanimoto I, Nishimura F, Takashiba S, FEMS Immunol Med Microbiol 2003 39 1 81 86 10.1016/S0928-8244(03)00224-4 14557000 (Pubitemid 37211464)